These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23496785)

  • 1. Biomarker rediscovery in diagnostics.
    Kiernan UA
    Expert Opin Med Diagn; 2008 Dec; 2(12):1391-400. PubMed ID: 23496785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic-based biomarker discovery for development of next generation diagnostics.
    Khalilpour A; Kilic T; Khalilpour S; Álvarez MM; Yazdi IK
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):475-491. PubMed ID: 28013407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
    Simpkins F; Czechowicz JA; Liotta L; Kohn EC
    Pharmacogenomics; 2005 Sep; 6(6):647-53. PubMed ID: 16143004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights of the Third Annual Biomarker World Congress: biomarkers for molecular diagnostics.
    Burczynski ME
    Expert Opin Med Diagn; 2007 Sep; 1(1):147-50. PubMed ID: 23489278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical proteomic biomarker discovery: taking a step back to leap forward.
    Listgarten J; Emili A
    Drug Discov Today; 2005 Dec; 10(23-24):1697-702. PubMed ID: 16376831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
    Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
    Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
    Pham TV; Piersma SR; Oudgenoeg G; Jimenez CR
    Expert Rev Mol Diagn; 2012 May; 12(4):343-59. PubMed ID: 22616700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.
    Zhang Z; Chan DW
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):2995-9. PubMed ID: 20962299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
    Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
    Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary protein biomarkers of cancer.
    McNeil BK; Getzenberg RH
    Expert Opin Med Diagn; 2009 May; 3(3):263-73. PubMed ID: 23488462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free mass spectrometry-based protein quantification technologies in proteomic analysis.
    Wang M; You J; Bemis KG; Tegeler TJ; Brown DP
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):329-39. PubMed ID: 18579615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary proteomics in biomedical research.
    Zhang A; Sun H; Wang P; Wang X
    Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.